A simple skin biopsy test has shown a high accuracy rate in detecting an abnormal form of alpha-synuclein, the pathological hallmark of Parkinson’s disease, according to neurologists at Beth Israel Deaconess Medical Center.

From Roy Freeman and colleagues, first author Christopher H. Gibbons. Read more in the Harvard Gazette.